Abstract: An NMDA antagonist (such as ketamine) is administered with a safener (such as clonidine) in patients suffering from neurologic disorders other than pain. The ketamine is adminsitered at a dosage that causes slurred speech, for a span of several days. This treatment enables a patient's nervous system to return to a healthy “set point”, also called an improved stable neural homeostasis, in a manner similar to a broken bone healing itself if protected from jostling and reinjury by a cast. In at least some patients, this treatment can ease problems such as addictions to illegal or pain-killing drugs, nicotine, or alcohol, compulsive or criminal behavioral problems, severe depression, obsessive-compulsive disorders, phobias, etc. It may also provide some relief in some patients for problems such as chronic fatigue, chemical sensitivities, allergies, autoimmune disorders, and diabetes.

Abstract: A drug that inhibits NMDA receptors (such as ketamine, a surgical anesthetic) is continuously administered to patients suffering from neuropathic pain. Unless the NMDA antagonist drug has inherent safening activity, this treatment requires a “safener” drug to prevent the neurotoxic side effects of NMDA antagonists. One class of safener drugs that increase the efficacy of the treatment include alpha-2 adrenergic agonists, such as clonidine. The treatment lasts for several days and nights, continuously. A maximum tolerated dosage is titered for each patient, such as by observing slurring of speech, and the patient does not lose consciousness except during normal sleep. Magnesium and/or drugs that inhibit ketamine-degrading enzymes can also be used. Patients who suffered for years from chronic intractable pain emerged from this treatment with apparently permanent relief, or with lasting reductions in their levels of pain.

Abstract: An exercise device, including a belt assembly to be worn around the torso of the user having first and second layers formed of nylon or polypropylene. The belt assembly further includes a plurality of attachment rings connected to the belt assembly and hook and loop fastening strips for removably attaching the belt assembly to the torso of the user. The device further includes a pair of hand assemblies each including finger holes for receiving the fingers of the user, a hand strap for removably attaching each hand assembly to a hand of the user, and an elastic hand resistance member having attachment clips thereon for detachably connecting the hand assembly to one of the attachment rings on the belt assembly.

Abstract: An exercise device, including a belt assembly to be worn around the torso of the user having a plurality of layers wherein a first layer is formed of rigid plastic and a second layer is formed of a cushioning material. The belt assembly further includes upper and lower back support areas extending from the belt assembly, a plurality of attachment rings connected to the belt assembly and Velcro closure strips for removably attaching the belt assembly to the torso of the user. The device further includes a pair of hand assemblies each including finger holes for receiving the fingers of the user, a hand strap for removably attaching each hand assembly to a hand of the user, and an elastic hand resistance member having attachment clips thereon for detachably connecting the hand assembly to one of the attachment rings on the belt assembly.